{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:11:07Z","timestamp":1766754667920},"reference-count":70,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,25]]},"abstract":"Abstract<\/jats:title>Objectives<\/jats:title>Recombinant human erythropoietin (rhEPO) has been shown to effectively and safely prevent the anemia of prematurity and to reduce the transfusion need in very low birth weight (VLBW) infants and has been licensed for this indication in Europe in 1997. The objective of the study was to obtain information on the use or non-use of rhEPO in neonatal units in Germany and other European countries.<\/jats:p><\/jats:sec>Methods<\/jats:title>Anonymized 14-questions web-based questionnaire.<\/jats:p><\/jats:sec>Results<\/jats:title>Seventy-nine questionnaires from Germany and 63 questionnaires from other 15 European countries were completed. Of the responders, 39% indicated to use rhEPO routinely or occasionally in VLBW infants, whereas 61% responded to never use rhEPO in this population. The major reasons given for non-use were lack of recommendation in national guidelines (69%) and\/or doubt about efficacy of rhEPO to reduce transfusion need (53%). Twenty-seven percent of the responders indicated to use rhEPO for neonates with birth weights above 1,500\u00a0g. Neuroprotection in VLBW infants (26%) and hypoxic ischemic encephalopathy in term neonates (27%) were given as indications for off label use of rhEPO.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>This survey indicates that rhEPO is used for the anemia of prematurity as licensed in less than half of neonatal units in Germany and other European countries. On the other hand it seems to be used off label in neonates for neuroprotection in a considerable number of units although there is no final evidence on its neuroprotective effects.<\/jats:p><\/jats:sec>","DOI":"10.1515\/jpm-2020-0070","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T13:31:38Z","timestamp":1595424698000},"page":"744-750","source":"Crossref","is-referenced-by-count":6,"title":["Survey on clinical use and non-use of recombinant human erythropoietin in European neonatal units"],"prefix":"10.1515","volume":"48","author":[{"given":"Katharina","family":"Bolte","sequence":"first","affiliation":[{"name":"Zentrum fuer Kinder- und Jugendmedizin, Philipps-Universitaet Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf F.","family":"Maier","sequence":"additional","affiliation":[{"name":"Zentrum fuer Kinder- und Jugendmedizin, Philipps-Universitaet Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref331","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jpeds.2008.01.026","article-title":"Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants","volume":"152","year":"2008","journal-title":"J Pediatr"},{"key":"ref571","first-page":"CD003248","article-title":"Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes","volume":"9","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref01","first-page":"F182","article-title":"Factors related to transfusion in very low birth weight infants treated with erythropoietin","year":"1996","journal-title":"Arch Dis Child"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","year":"2008","journal-title":"Pediatrics"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(97)70089-1","article-title":"The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study","volume":"131","year":"1997","journal-title":"J Pediatr"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/jpme.1995.23.1-2.119","article-title":"Recombinant erythropoietin for prevention of anemia in preterm infants","volume":"23","year":"1995","journal-title":"J Perinat Med"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/jpme.1995.23.1-2.119","article-title":"Recombinant erythropoietin for prevention of anemia in preterm infants","volume":"23","year":"1995","journal-title":"J Perinat Med"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.arcped.2015.07.001","article-title":"L\u2019\u00e9rythropo\u00ef\u00e9tine humaine recombinante chez le nouveau-n\u00e9: recommandations pour la pratique clinique de la Soci\u00e9t\u00e9\u00a0fran\u00e7aise de n\u00e9onatologie","volume":"22","year":"2015","journal-title":"Arch Pediatr"},{"key":"ref191","first-page":"CD004863","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants","volume":"2","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref201","first-page":"CD004868","article-title":"Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants","volume":"1","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2018.03.014","article-title":"The erythropoietin promoter variant rs1617640 is not associated with severe retinopathy of prematurity, independent of treatment with erythropoietin","volume":"199","year":"2018","journal-title":"J Pediatr"},{"key":"ref551","first-page":"CD004868","article-title":"Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants","volume":"1","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1537-2995.1995.351196110899.x","article-title":"A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity","volume":"35","year":"1995","journal-title":"Transfusion"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"e20164317","DOI":"10.1542\/peds.2016-4317","article-title":"Prophylactic early erythropoietin for neuroprotection in preterm infants: a meta-analysis","volume":"139","year":"2017","journal-title":"Pediatrics"},{"key":"ref591","first-page":"3","article-title":"Erythropoietin \u2013\u00a0zus\u00e4tzliches Risiko einer Retinopathie bei Fr\u00fchgeborenen nicht auszuschlie\u00dfen. Bulletin zur Arzneimittelsicherheit","volume":"3","year":"2015","journal-title":"Informationen aus BfArM und PEI"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2018.03.014","article-title":"The erythropoietin promoter variant rs1617640 is not associated with severe retinopathy of prematurity, independent of treatment with erythropoietin","volume":"199","year":"2018","journal-title":"J Pediatr"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","year":"1995","journal-title":"Pediatrics"},{"key":"ref131","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"4","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jpeds.2008.01.026","article-title":"Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants","volume":"152","year":"2008","journal-title":"J Pediatr"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","year":"1995","journal-title":"Pediatrics"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2016.5504","article-title":"Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial","volume":"315","year":"2016","journal-title":"JAMA"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2011.11.003","article-title":"From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease","volume":"31","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2016.5504","article-title":"Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial","volume":"315","year":"2016","journal-title":"JAMA"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","year":"2000","journal-title":"Eur J Pediatr"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(97)70089-1","article-title":"The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study","volume":"131","year":"1997","journal-title":"J Pediatr"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3476(05)83559-0","article-title":"Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration","volume":"122","year":"1993","journal-title":"J Pediatr"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/jp.2010.80","article-title":"Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants","volume":"31","year":"2011","journal-title":"J Perinatol"},{"key":"ref351","first-page":"F182","article-title":"Factors related to transfusion in very low birth weight infants treated with erythropoietin","year":"1996","journal-title":"Arch Dis Child"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ije\/dyz270","article-title":"Cohort profile: effective perinatal intensive care in Europe (EPICE) very preterm birth cohort","volume":"49","year":"2020","journal-title":"Int J Epidemiol"},{"key":"ref251","journal-title":"NeoRecormon. Procedural steps taken and scientific information after the authorisation. Amendment 15\/07\/2016"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","year":"2000","journal-title":"Eur J Pediatr"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1651-2227.1996.tb14069.x","article-title":"Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism","volume":"85","year":"1996","journal-title":"Acta Paediatr"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1651-2227.1996.tb14069.x","article-title":"Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism","volume":"85","year":"1996","journal-title":"Acta Paediatr"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","year":"2008","journal-title":"Pediatrics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-3476(05)82671-X","article-title":"Effects of recombinant human erythropoietin in infants with the\u00a0anemia of prematurity: a pilot study","volume":"116","year":"1990","journal-title":"J Pediatr"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-3782(01)00115-3","article-title":"The role of blood transfusions and iron intake on retinopathy of prematurity","volume":"62","year":"2001","journal-title":"Early Hum Dev"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.arcped.2015.07.001","article-title":"L\u2019\u00e9rythropo\u00ef\u00e9tine humaine recombinante chez le nouveau-n\u00e9: recommandations pour la pratique clinique de la Soci\u00e9t\u00e9\u00a0fran\u00e7aise de n\u00e9onatologie","volume":"22","year":"2015","journal-title":"Arch Pediatr"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2011.11.003","article-title":"From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease","volume":"31","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3476(05)83559-0","article-title":"Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration","volume":"122","year":"1993","journal-title":"J Pediatr"},{"key":"ref481","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"4","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","article-title":"The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European multicentre erythropoietin study group","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41390-018-0186-6","article-title":"Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity","volume":"86","year":"2019","journal-title":"Pediatr Res"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","article-title":"Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1,000 g","volume":"141","year":"2002","journal-title":"J Pediatr"},{"key":"ref601","journal-title":"NeoRecormon. Procedural steps taken and scientific information after the authorisation. Amendment 15\/07\/2016"},{"key":"ref361","first-page":"904","article-title":"Transfusion therapy in neonates","volume":"145","year":"1991","journal-title":"Am J Dis Child"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/jpme.1998.26.1.43","article-title":"Low degree of regionalization and high transfusion rates in very low birth weight infants: a survey in Germany","volume":"26","year":"1998","journal-title":"J Perinat Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","article-title":"The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European multicentre erythropoietin study group","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"ref241","first-page":"3","article-title":"Erythropoietin \u2013\u00a0zus\u00e4tzliches Risiko einer Retinopathie bei Fr\u00fchgeborenen nicht auszuschlie\u00dfen. Bulletin zur Arzneimittelsicherheit","volume":"3","year":"2015","journal-title":"Informationen aus BfArM und PEI"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0028-1103024","article-title":"A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants","volume":"26","year":"2009","journal-title":"Am J Perinatol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000047097","article-title":"The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential","volume":"79","year":"2001","journal-title":"Biol Neonat"},{"key":"ref221","first-page":"CD003248","article-title":"Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes","volume":"9","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref561","first-page":"i2976","article-title":"Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort","volume":"354","year":"2016","journal-title":"BMJ"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1537-2995.1995.351196110899.x","article-title":"A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity","volume":"35","year":"1995","journal-title":"Transfusion"},{"key":"ref301","first-page":"CD004865","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"2","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0028-1103024","article-title":"A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants","volume":"26","year":"2009","journal-title":"Am J Perinatol"},{"key":"ref541","first-page":"CD004863","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants","volume":"2","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref211","first-page":"i2976","article-title":"Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort","volume":"354","year":"2016","journal-title":"BMJ"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000047097","article-title":"The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential","volume":"79","year":"2001","journal-title":"Biol Neonat"},{"key":"ref11","first-page":"904","article-title":"Transfusion therapy in neonates","volume":"145","year":"1991","journal-title":"Am J Dis Child"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41390-018-0186-6","article-title":"Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity","volume":"86","year":"2019","journal-title":"Pediatr Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/jpme.1998.26.1.43","article-title":"Low degree of regionalization and high transfusion rates in very low birth weight infants: a survey in Germany","volume":"26","year":"1998","journal-title":"J Perinat Med"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-3476(05)82671-X","article-title":"Effects of recombinant human erythropoietin in infants with the\u00a0anemia of prematurity: a pilot study","volume":"116","year":"1990","journal-title":"J Pediatr"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","article-title":"Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1,000 g","volume":"141","year":"2002","journal-title":"J Pediatr"},{"key":"ref651","first-page":"CD004865","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"2","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/jp.2010.80","article-title":"Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants","volume":"31","year":"2011","journal-title":"J Perinatol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ije\/dyz270","article-title":"Cohort profile: effective perinatal intensive care in Europe (EPICE) very preterm birth cohort","volume":"49","year":"2020","journal-title":"Int J Epidemiol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-3782(01)00115-3","article-title":"The role of blood transfusions and iron intake on retinopathy of prematurity","volume":"62","year":"2001","journal-title":"Early Hum Dev"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"e20164317","DOI":"10.1542\/peds.2016-4317","article-title":"Prophylactic early erythropoietin for neuroprotection in preterm infants: a meta-analysis","volume":"139","year":"2017","journal-title":"Pediatrics"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpme\/48\/7\/article-p744.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2020-0070\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T23:53:06Z","timestamp":1667519586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2020-0070\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":70,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1515\/jpm-2020-0070","relation":{},"ISSN":["1619-3997","0300-5577"],"issn-type":[{"value":"1619-3997","type":"electronic"},{"value":"0300-5577","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}